Pyrrolidine dithiocarbamate protects the piriform cortex in the pilocarpine status epilepticus model

Epilepsy Research

Volumn 87, Issue 2-3, 2009, Pages 177-183

  Soerensen, Jonna ^a   Pekcec, Anton ^a   Fuest, Christina ^a   Nickel, Astrid ^a   Potschka, Heidrun ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Neuroprotection; NF B; PDTC; Pilocarpine; Piriform cortex; Status epilepticus

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PILOCARPINE; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; EPILEPTIC STATE; FEMALE; HIPPOCAMPUS; INTERNEURON; LOW DRUG DOSE; MORTALITY; NERVE CELL LESION; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; PYRIFORM CORTEX; RAT; REPEATED DRUG DOSE;

ANIMALS; ANTIOXIDANTS; CELL COUNT; CYTOPROTECTION; FEMALE; HIPPOCAMPUS; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OLFACTORY PATHWAYS; PILOCARPINE; PYRROLIDINES; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; STATUS EPILEPTICUS; THIOCARBAMATES;

EID: 70449642424     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.08.013     Document Type: Article

References (25)

1. Acharya M.M., Hattiangady B., and Shetty A.K. Progress in neuroprotective strategies for preventing epilepsy. Prog. Neurobiol. 84 (2008) 363-404
2. Andre V., Dube C., Francois J., Leroy C., Rigoulot M.A., Roch C., Namer I.J., and Nehlig A. Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model. Epilepsia 48 Suppl. 5 (2007) 41-47
3. Andre V., Rigoulot M.A., Koning E., Ferrandon A., and Nehlig A. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia 44 (2003) 893-903
4. Brandt C., Gastens A.M., Sun M., Hausknecht M., and Loscher W. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 51 (2006) 789-804
5. Della Ragione F., Cucciolla V., Borriello A., Della Pietra V., Manna C., Galletti P., and Zappia V. Pyrrolidine dithiocarbamate induces apoptosis by a cytochrome c-dependent mechanism. Biochem. Biophys. Res. Commun. 268 (2000) 942-946
6. Glien M., Brandt C., Potschka H., Voigt H., Ebert U., and Loscher W. Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy. Epilepsy Res. 46 (2001) 111-119
7. Lerner-Natoli M., Montpied P., Rousset M.C., Bockaert J., and Rondouin G. Sequential expression of surface antigens and transcription factor NFkappaB by hippocampal cells in excitotoxicity and experimental epilepsy. Epilepsy Res. 41 (2000) 141-154
8. Madrigal J.L., Moro M.A., Lizasoain I., Lorenzo P., Castrillo A., Bosca L., and Leza J.C. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J. Neurochem. 76 (2001) 532-538
9. Mattson M.P., and Meffert M.K. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 13 (2006) 852-860
10. Michaelis E.K. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54 (1998) 369-415
11. Nehlig A. What is animal experimentation telling us about new drug treatments of status epilepticus?. Epilepsia 48 8 Suppl. (2007) 78-81
12. Nurmi A., Goldsteins G., Narvainen J., Pihlaja R., Ahtoniemi T., Grohn O., and Koistinaho J. Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia. Free Radic. Biol. Med. 40 (2006) 1776-1784
13. Nurmi A., Vartiainen N., Pihlaja R., Goldsteins G., Yrjanheikki J., and Koistinaho J. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J. Neurochem. 91 (2004) 755-765
14. Peterson S.L., Morrow D., Liu S., and Liu K.J. Hydroethidine detection of superoxide production during the lithium-pilocarpine model of status epilepticus. Epilepsy Res. 49 (2002) 226-238
15. Pitkanen A. Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology 59 (2002) S27-33
16. Pitkanen A., and Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav. 14 Suppl. 1 (2009) 16-25
17. Pitkanen A., Narkilahti S., Bezvenyuk Z., Haapalinna A., and Nissinen J. Atipamezole, an alpha(2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats. Epilepsy Res. 61 (2004) 119-140
18. Schreck R., Meier B., Mannel D.N., Droge W., and Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175 (1992) 1181-1194
19. Shin E.J., Jhoo J.H., Kim W.K., Jhoo W.K., Lee C., Jung B.D., and Kim H.C. Protection against kainate neurotoxicity by pyrrolidine dithiocarbamate. Clin. Exp. Pharmacol. Physiol. 31 (2004) 320-326
20. Tejada S., Roca C., Sureda A., Rial R.V., Gamundi A., and Esteban S. Antioxidant response analysis in the brain after pilocarpine treatments. Brain Res. Bull. 69 (2006) 587-592
21. Tejada S., Sureda A., Roca C., Gamundi A., and Esteban S. Antioxidant response and oxidative damage in brain cortex after high dose of pilocarpine. Brain Res. Bull. 71 (2007) 372-375
22. Unkruer B., Pekcec A., Fuest C., Wehmeyer A., Balda M.S., Horn A., Baumgartner W., and Potschka H. Cellular localization of Y-box binding protein 1 in brain tissue of rats, macaques, and humans. BMC Neurosci. 10 (2009) 28
23. Voutsinos-Porche B., Koning E., Kaplan H., Ferrandon A., Guenounou M., Nehlig A., and Motte J. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol. Dis. 17 (2004) 385-402
24. Walker M. Neuroprotection in epilepsy. Epilepsia 48 Suppl. 8 (2007) 66-68
25. Weise J., Engelhorn T., Dorfler A., Aker S., Bahr M., and Hufnagel A. Expression time course and spatial distribution of activated caspase-3 after experimental status epilepticus: contribution of delayed neuronal cell death to seizure-induced neuronal injury. Neurobiol. Dis. 18 (2005) 582-590